Page last updated: 2024-10-30

metformin and Liver Cirrhosis, Biliary

metformin has been researched along with Liver Cirrhosis, Biliary in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.

Research Excerpts

ExcerptRelevanceReference
"Metformin treatment neither induced obvious hypoglycemic event nor altered hemodynamics in cirrhotic rats."1.46Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats. ( Chang, CC; Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Ko, MT; Lee, FY; Lee, SD; Lee, WS, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ko, MT1
Huang, HC1
Lee, WS1
Chuang, CL1
Hsin, IF1
Hsu, SJ1
Lee, FY1
Chang, CC1
Lee, SD1

Other Studies

1 other study available for metformin and Liver Cirrhosis, Biliary

ArticleYear
Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats.
    Journal of the Chinese Medical Association : JCMA, 2017, Volume: 80, Issue:8

    Topics: AMP-Activated Protein Kinases; Animals; Cyclooxygenase 1; Hepatopulmonary Syndrome; Liver Cirrhosis;

2017